2016
Multiple sclerosis
Axisa PP, Hafler DA. Multiple sclerosis. Current Opinion In Neurology 2016, 29: 345-353. PMID: 27058221, PMCID: PMC7882195, DOI: 10.1097/wco.0000000000000319.Peer-Reviewed Original ResearchConceptsMultiple sclerosisGenome-wide association studiesAssociation studiesMultiple sclerosis (MS) etiologyMultiple sclerosis progressionMultiple sclerosis patientsHigh-throughput genetic analysisImmune cell functionNumerous candidate biomarkersWide association studyMechanisms of neurodegenerationImmunomodulatory treatmentSclerosis patientsClinical outcomesTreatment arsenalDisease progressionImmune regulationSclerosisNew biomarkersCandidate biomarkersPatient careGenetic variationGenetic analysisCell functionProgression
1994
Human T cell lymphotropic virus type I-induced T cell activation. Resistance to TGF-beta 1-induced suppression.
Höllsberg P, Ausubel LJ, Hafler DA. Human T cell lymphotropic virus type I-induced T cell activation. Resistance to TGF-beta 1-induced suppression. The Journal Of Immunology 1994, 153: 566-73. PMID: 8021495, DOI: 10.4049/jimmunol.153.2.566.Peer-Reviewed Original ResearchConceptsT cell clonesT cell activationHuman T-cell lymphotropic virus type ILymphotropic virus type IVirus type ICell activationCell clonesT cellsCD3/TCR complexHTLV-I myelopathyT cell proliferationType IImmune regulationHTLVHyperphosphorylation of pRbProductive infectionCell cycle progressionCell proliferationTCR complexPatientsG1 phaseInfectionSingle cell cloningCycle progressionActivation
1992
Experimental Approaches to Specific Immunotherapy in Multiple Sclerosis
Hafler D, Brod S, Weiner H. Experimental Approaches to Specific Immunotherapy in Multiple Sclerosis. Clinical Medicine And The Nervous System 1992, 301-307. DOI: 10.1007/978-1-4471-3184-7_15.Peer-Reviewed Original ResearchMultiple sclerosisT cellsAutoimmune diseasesNervous systemAutoreactive T cellsPatient T cellsCentral nervous systemInitial inductionMyelin basic proteinSpecific immunotherapyImmune targetsWhite matter structuresImmune regulationProteolipid proteinSclerosisMatter structuresDiseaseBasic proteinDestructive processesImmunotherapyDemyelinationInflammationCareful regulation